These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3183524)

  • 1. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans.
    Kempen HJ; Glatz JF; Gevers Leuven JA; van der Voort HA; Katan MB
    J Lipid Res; 1988 Sep; 29(9):1149-55. PubMed ID: 3183524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of changes in serum lathosterol during treatment with simvastatin to evaluate the role of lathosterol as a parameter for whole body cholesterol synthesis.
    De Cuyper I; Wolthers BG; van Doormaal JJ; Wijnandts PN
    Clin Chim Acta; 1993 Oct; 219(1-2):123-30. PubMed ID: 8306452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lathosterol levels in human subjects reflect changes in whole body cholesterol synthesis induced by lovastatin but not dietary cholesterol.
    Duane WC
    J Lipid Res; 1995 Feb; 36(2):343-8. PubMed ID: 7751822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of simvastatin and pravastatin on cholesterol synthesis in patients with primary hypercholesterolemia.
    Feillet C; Farnier M; Monnier LH; Percheron C; Colette C; Descomps B; Crastes De Paulet A
    Atherosclerosis; 1995 Dec; 118(2):251-8. PubMed ID: 8770319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the use of serum lathosterol concentration to assess whole-body cholesterol synthesis in rabbits.
    Meijer GW; Van der Palen JG; De Vries H; Kempen HJ; Van der Voort HA; Van Zutphen LF; Beynen AC
    J Lipid Res; 1992 Feb; 33(2):281-6. PubMed ID: 1569379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serum lathosterol to cholesterol ratio, an index of cholesterol synthesis, is not elevated in patients with glomerular proteinuria and is not associated with improvement of hyperlipidemia in response to antiproteinuric treatment.
    Dullaart RP; Gansevoort RT; Sluiter WJ; de Zeeuw D; de Jong PE
    Metabolism; 1996 Jun; 45(6):723-30. PubMed ID: 8637447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dietary fat content on plasma noncholesterol sterol concentrations in patients with familial hypercholesterolemia treated with simvastatin.
    Chisholm A; Sutherland W; Ball M
    Metabolism; 1994 Mar; 43(3):310-4. PubMed ID: 8139479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia.
    Human JA; Ubbink JB; Jerling JJ; Delport R; Vermaak WJ; Vorster HH; Lagendijk J; Potgieter HC
    Clin Chim Acta; 1997 Jul; 263(1):67-77. PubMed ID: 9247729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia.
    Naoumova RP; Marais AD; Mountney J; Firth JC; Rendell NB; Taylor GW; Thompson GR
    Atherosclerosis; 1996 Jan; 119(2):203-13. PubMed ID: 8808497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin: a review of its pharmacology and clinical use.
    Mauro VF; MacDonald JL
    DICP; 1991 Mar; 25(3):257-64. PubMed ID: 2028634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of simvastatin on atherogenic blood lipid pattern].
    Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F
    Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia].
    Aubert I; Emmerich J; Charpak Y; Chanu B; Dachet C; Herlich D; Besseau M; Rouffy J; Jacotot B
    Presse Med; 1988 May; 17(18):901-4. PubMed ID: 2968595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens.
    Mosley ST; Kalinowski SS; Schafer BL; Tanaka RD
    J Lipid Res; 1989 Sep; 30(9):1411-20. PubMed ID: 2513368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients.
    Agheli N; Jacotot B
    Br J Clin Pharmacol; 1991 Oct; 32(4):423-8. PubMed ID: 1958434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of simvastatin (MK-733) on the regulation of cholesterol synthesis in Hep G2 cells.
    Nagata Y; Hidaka Y; Ishida F; Kamei T
    Biochem Pharmacol; 1990 Aug; 40(4):843-50. PubMed ID: 2167097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.
    Leclercq V; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):76-81. PubMed ID: 2921098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation.
    Vuorio AF; Gylling H; Turtola H; Kontula K; Ketonen P; Miettinen TA
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):500-6. PubMed ID: 10669649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of simvastatin on adrenal corticosteroid production and urinary mevalonate during adrenocorticotropin stimulation in patients with heterozygous familial hypercholesterolemia.
    Prihoda JS; Pappu AS; Smith FE; Illingworth DR
    J Clin Endocrinol Metab; 1991 Mar; 72(3):567-74. PubMed ID: 1847705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia.
    Mol MJ; Erkelens DW; Gevers Leuven JA; Schouten JA; Stalenhoef AF
    Atherosclerosis; 1988 Feb; 69(2-3):131-7. PubMed ID: 3279966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.